Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection
about
Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central ChinaChanging Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in ChinaHepatitis C virus infection.APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Virus-related liver cirrhosis: molecular basis and therapeutic options.Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.Risk factors of hepatitis C virus transmission and genotype distribution in former blood donors from Chinese rural area.24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled TrialAbnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infectionHepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6.Traceability, reproducibility and clinical evaluation of Sansure Realtime HCV RNA assay.Phylogenetic analysis of HCV subgenotypes in patients from Sichuan province in China based on the NS5B region.Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients.Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China.The global burden of liver disease: the major impact of ChinaUp-regulation of Plasma Hexosylceramide (d18: 1/18: 1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort StudyMolecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysisHepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional studyFavorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment.Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.Abnormal phenotypic features of IgM+B cell subsets in patients with chronic hepatitis C virus infection.EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C.Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern China.Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China.Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients.Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.Hepatitis C Virus Genotype Analyses in Chronic Hepatitis C Patients and Individuals With Spontaneous Virus Clearance Using a Newly Developed Serotyping Assay.Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study.A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin.Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea.IL28B rs12980275 polymorphism shows association with response to treatment in Pakistani patients with chronic hepatitis C.Frequency of interleukin 28B rs12979860 C>T variants in Filipino patients chronically infected with hepatitis B virus.Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China.Hepatitis C virus genotypes and subtypes circulating in Mainland China.A Public Health Analysis on Gaps in Disease Monitoring and Opportunities for Improved Care for the Management of Hepatitis B and C.Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China.A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.
P2860
Q28547657-116B04DC-C6FE-47A9-A755-8ECE04E34EC5Q28553922-8F7A55AC-3D16-46F2-94B8-E57C001BE0C9Q30235491-7C7C4A89-79CC-41EC-954C-DAA3B23AE8CCQ30250088-64BF2AFA-649C-4DF0-A348-BC48AC237FECQ33718267-5AEB5979-6494-4681-911F-A71D3C144C33Q34298265-6D6B3092-4698-4F18-AD47-BD7E50248A5FQ35165283-A4354D48-3D27-4AFB-8388-E91524589644Q35824222-D0D78CCE-D364-4468-85BE-2C2739B29A2DQ35848304-81B1E37D-B51E-4161-BE3D-ABB8481E1282Q35885715-6C1EF0E5-3AFC-4C01-987F-A383B6B81D4BQ35910953-DA3F1C8B-6D9C-42BC-98E6-62B670DC7938Q36041672-646985A3-7995-4EC9-87BC-1884CA85DEFFQ36182240-F3C93813-2E70-4077-93DF-229A9072604AQ36336005-6B05F3C7-A713-4CD9-939A-DDD35CBAD50BQ36901892-46090097-8CA9-476D-9F03-EA9E9A15FEEFQ37003642-2EA06E9C-A572-42C6-8AC3-2F2E5CEBA5D9Q37350196-0E6590D3-1E2B-4F54-92FD-732FE6FD8B28Q37356018-D35DA51F-844D-4C71-A7D8-C6D66F6B66DAQ37625268-34F61089-3E05-4E04-A9CE-BC3E88EC4869Q38459012-7883D42B-DDB9-4EBC-95A0-4F1EC957A844Q38526903-A6A16161-D6EB-48DF-8433-7872907DB8FBQ38611469-32AB1524-7B58-4550-86B3-83CB26BBF0BAQ40082368-79887469-7B88-4ADC-B466-42F4EEA6F3BCQ40124597-15C7070C-4EFB-4C28-887A-618166BF90B8Q40137243-A3C5BB12-BAB6-48F6-BBCA-07DC1F941A78Q40176497-019E69BB-A258-4E98-ACBB-934CAAE72BA2Q40481366-B626B54E-6F25-4EB9-86C2-5341579C524EQ40604753-F0A640B7-F227-449F-9CFA-A1C6CBB48F83Q40650369-B625523F-2C0A-4CC7-BC19-75A5E5CF32EEQ40705557-D29E8684-1EE7-4F60-895C-39BCB62341F0Q40706475-D7573916-6E23-4A4B-95AD-730752D7D689Q40745549-81900C58-D9B7-4D0E-A067-C1BC03C1A30DQ40829783-4D2E3699-1B43-4117-81A1-A4F08EC068B8Q41503237-424EEE0B-ECB6-4EC2-B204-516A8246F67DQ41665537-AB35FFE2-451F-44DA-9D84-43E2CE903EA0Q45324124-1ADD9349-A934-4196-85B0-9C51114815BCQ45325441-3AAEE313-F505-46D6-A540-C31EC2365D9EQ52645814-CDD33B65-2415-4BBC-973F-AB98C1B5794CQ54238657-CDF9821B-FF4F-4E52-B154-4415C569756DQ55406543-52444509-388B-4716-B503-D164F52958DC
P2860
Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Distribution and clinical corr ...... ic hepatitis C virus infection
@ast
Distribution and clinical corr ...... ic hepatitis C virus infection
@en
Distribution and clinical corr ...... ic hepatitis C virus infection
@nl
type
label
Distribution and clinical corr ...... ic hepatitis C virus infection
@ast
Distribution and clinical corr ...... ic hepatitis C virus infection
@en
Distribution and clinical corr ...... ic hepatitis C virus infection
@nl
prefLabel
Distribution and clinical corr ...... ic hepatitis C virus infection
@ast
Distribution and clinical corr ...... ic hepatitis C virus infection
@en
Distribution and clinical corr ...... ic hepatitis C virus infection
@nl
P2093
P2860
P356
P1476
Distribution and clinical corr ...... ic hepatitis C virus infection
@en
P2093
Guozhong Gong
Haiying Zhang
Hui Zhuang
Huiying Rao
P2860
P304
P356
10.1111/JGH.12398
P577
2014-03-01T00:00:00Z